AILERON THERAPEUTICS INC·4

Jul 27, 6:27 PM ET

Gallagher Brian M. Jr. 4

4 · AILERON THERAPEUTICS INC · Filed Jul 27, 2017

Insider Transaction Report

Form 4
Period: 2017-07-25
Transactions
  • Award

    Stock Option (right to buy)

    2017-07-25+20,00020,000 total
    Exercise: $13.00Exp: 2027-07-24Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]This option was granted on July 25, 2017. The shares underlying the option are scheduled to vest in equal annual installments over three years from July 25, 2017. The option was granted to the Reporting Person as director's compensation. As a Vice President at S.R. One, Limited and an employee of GlaxoSmithKline LLC, the Reporting Person is obligated to transfer any shares issued under the option to S.R. One, Limited, an indirect wholly-owned subsidiary of GlaxoSmithKline plc.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION